TransMedics Group (TMDX) Tops Q4 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pre-Open Stock Movers 03/02: (INUV) (TMDX) (RKT) Higher; (FGEN) (LODE) (AI) Lower (more...)
March 2, 2021 9:28 AM ESTToday's Pre-Open Stock Movers
Inuvo (NYSE: INUV) 24% HIGHER; On February 24, 2021, Vertro, Inc., a wholly-owned subsidiary of Inuvo, Inc. entered into a Google Services Agreement with Google LLC, effective as of March 1, 2021.
TransMedics Group (TMDX) PT Raised to $40 at Oppenheimer
March 2, 2021 6:14 AM ESTOppenheimer analyst Suraj Kalia raised the price target on TransMedics Group (NASDAQ: TMDX) to $40.00 (from $25.00) while maintaining an Outperform rating.
The analyst commented, "After close (3/1), TransMedics announced FDA has communicated its intent to hold a Circulatory Systems Device Advisory Panel meeting on 4/6. While... More
TransMedics Group (TMDX) Announces Scheduling of OCS Heart FDA Advisory Committee Meeting
March 1, 2021 4:17 PM ESTTransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that the FDA's Office of Health Technology 2 (Cardiovascular Devices) has communicated its intent to hold a Circulatory... More
